Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Evotec SE (EVO)

  • Technical Exchange News
  • May 24, 2024, 18:38 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Landos Biopharma Inc (LABP)

  • Technical Exchange News
  • May 24, 2024, 07:08 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Landos Biopharma, Inc. - Common Stock.

Comment Full text

Landos Biopharma Inc (LABP)

  • Technical Exchange News
  • May 24, 2024, 07:08 UTC
  • 42
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Landos Biopharma, Inc. - Common Stock. New value: Landos Biopharma, Inc. - Common Stock.

Comment Full text

Landos Biopharma Inc (LABP)

  • Technical Exchange News
  • May 24, 2024, 07:08 UTC
  • 42
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Landos Biopharma, Inc. - Common Stock.

Comment Full text

Vivos Therapeutics (VVOS)

  • Technical Exchange News
  • May 24, 2024, 02:03 UTC
  • 41
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Procaps Group SA (PROC)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 42
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Nexalin Technology Inc (NXLIW)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Nexalin Technology Inc (NXL)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Enveric Biosciences Inc. (ENVB)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

eFFECTOR Therapeutics Inc. (EFTRW)

  • Technical Exchange News
  • May 24, 2024, 02:02 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 948
  • 949
  • 950
  • 951
  • 952
  • Next

Search

News categories

  • Technical Exchange News(14586)
  • Event(6229)
  • SEC News(383760)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(234782)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin